The original concept, proposed by Staerz and Bevan, demonstrated that hybrid antibodies capable of simultaneously binding CD3 and a tumor-associated antigen could induce apoptosis independently of MHC presentation (57). The gene discussed is HLA-C; the disease is neoplasm.